학술논문
Endophthalmitis Outbreak Associated with Repackaged Bevacizumab.
Document Type
Article
Author
Source
Subject
*EYE inflammation
*BEVACIZUMAB
*EPIDEMIC research
*EMERGING infectious diseases
*
*
*
Language
ISSN
1080-6040
Abstract
The article presents a study on the outbreak of acute endophthalmitis associated with repackaged bevacizumab in Georgia and Indiana from February to March 2013. The repackaging of bevacizumab at a pharmacy has caused the outbreak which led microbial contamination that can result in vision loss. The antineoplastic agent is used to treat retinal disorders, such as age-related macular degeneration.